Heart surgery fluid use under the microscope: albumin study launched
NCT ID NCT06395480
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study observes how albumin and other fluids are given to adults during heart surgery at multiple hospitals. Researchers will track usage patterns and patient outcomes to fill knowledge gaps. The goal is to improve future care for cardiac surgery patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand when to use albumin during heart surgery, potentially leading to improved guidelines and patient outcomes.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not change practice on their own.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALBUMIN LEVELS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L 3N6, Canada
-
Toronto General Hospital - University Health Network
Toronto, Ontario, M5G 2C4, Canada